Peptide Therapeutics intermediate
Milestone 028: Oligopeptide Research Reference
1990: First recombinant monoclonal antibody (abciximab) approved. This peptide or oligopeptide is studied for its biological activity, structure-activity rel...
By Encyclopeptide Editorial | 1 min read
milestone-028 peptide research
Overview
1990: First recombinant monoclonal antibody (abciximab) approved.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Milestone 028” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Milestone 028: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept